Carcinogenesis, Vol. 23, No. 3, 411-417,
March 2002
© 2002 Oxford University Press
CANCER BIOLOGY |
Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice
1 Department of Pharmaceutical Sciences and
2 Department of Pharmacology, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262, USA
Present address: CIIT, 6 Davis Drive, Research Triangle Park, NC 27709, USA
We have reported previously [Bauer,A.K. et al. (2001) Exp. Lung Res., 27, 197–216] that the 13 CXB recombinant inbred mouse strains derived from BALB/cByJ and C57BL/6J progenitors vary in their responsiveness to both lung tumor promotion and pulmonary inflammation induced by chronic administration of butylated hydroxytoluene (BHT). Herein we have applied these data, along with markers known to be polymorphic among these strains, to conduct linkage analysis of these susceptibilities. This enabled us to assign provisional quantitative trait loci (QTL) that govern these strain variations in susceptibility as a genetic approach to assessing the influence of inflammation on tumorigenesis. A Chr 15 (39.1–55.6 cM) QTL regulated susceptibility to two-stage carcinogensis, a protocol in which chronic BHT exposure followed a single urethane injection; a similar QTL on Chr 15 (46.7–61.7 cM) influenced BHT induction of cyclooxygenase-2 (COX-2) expression. A Chr 18 (37–41 cM) QTL modulated both the number of lung tumors induced by 3-methylcholanthrene (MCA) injection with subsequent treatment with BHT as well as BHT-induced ingress of macrophages into airways. Other chromosomal sites that affected either the degree of BHT-elicited macrophage infiltration, Chr 9 (48–61 cM), or COX-2 induction, Chr 10 (59–65 cM), were reported to influence susceptibility to lung tumorigenesis in other strains. The fact that common chromosomal locations regulate both inflammation and carcinogenesis suggests a pathogenic role of inflammatory mediators in tumor development that may be exploited for chemoprevention of lung cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. K. Bauer and E. A. Rondini REVIEW PAPER: The Role of Inflammation in Mouse Pulmonary Neoplasia Vet. Pathol., May 1, 2009; 46(3): 369 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Coates, J. K. Rundle, S. A. Lorimore, and E. G. Wright Indirect Macrophage Responses to Ionizing Radiation: Implications for Genotype-Dependent Bystander Signaling Cancer Res., January 15, 2008; 68(2): 450 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Lemay and C. K. Haston Bleomycin-induced pulmonary fibrosis susceptibility genes in AcB/BcA recombinant congenic mice Physiol Genomics, September 21, 2005; 23(1): 54 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Bauer, A. M. Malkinson, and S. R. Kleeberger Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L685 - L703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Meyer, L. D. Dwyer-Nield, G. J. Hurteau, R. L. Keith, E. O'Leary, M. You, J. V. Bonventre, R. A. Nemenoff, and A. M. Malkinson Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2 Carcinogenesis, August 1, 2004; 25(8): 1517 - 1524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Kisley, B. S. Barrett, A. K. Bauer, L. D. Dwyer-Nield, B. Barthel, A. M. Meyer, D. C. Thompson, and A. M. Malkinson Genetic Ablation of Inducible Nitric Oxide Synthase Decreases Mouse Lung Tumorigenesis Cancer Res., December 1, 2002; 62(23): 6850 - 6856. [Abstract] [Full Text] [PDF]
|
|